Monogene and polygene therapy for the treatment of experimental prostate cancers by use of apoptotic genes bax and bad driven by the prostate-specific promoter ARR(2)PB.
- DOI
- 10.1089/10430340260395901
- Published
- 2002 Nov 20
- Container
- Human gene therapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1089/10430340260395901,
title = {Monogene and polygene therapy for the treatment of experimental prostate cancers by use of apoptotic genes bax and bad driven by the prostate-specific promoter ARR(2)PB.},
author = {Zhang Y and Yu J and Unni E and Shao TC and Nan B and Snabboon T and Kasper S and Andriani F and Denner L and Marcelli M},
year = {2002},
journal = {Human gene therapy},
doi = {10.1089/10430340260395901},
url = {https://doi.org/10.1089/10430340260395901}
}RIS
TY - JOUR TI - Monogene and polygene therapy for the treatment of experimental prostate cancers by use of apoptotic genes bax and bad driven by the prostate-specific promoter ARR(2)PB. AU - Zhang Y AU - Yu J AU - Unni E AU - Shao TC AU - Nan B AU - Snabboon T AU - Kasper S AU - Andriani F AU - Denner L AU - Marcelli M PY - 2002 JO - Human gene therapy DO - 10.1089/10430340260395901 UR - https://doi.org/10.1089/10430340260395901 ER -
APA
Y, Z., J, Y., E, U., TC, S., B, N., T, S., S, K., F, A., L, D., & M, M. (2002). Monogene and polygene therapy for the treatment of experimental prostate cancers by use of apoptotic genes bax and bad driven by the prostate-specific promoter ARR(2)PB.. Human gene therapy. https://doi.org/10.1089/10430340260395901
Source records
- pubmed · retrieved 2026-09-26T02:40:16.928Z